Pfizer Canada

Oct 08, 2024

Pfizer Canada and the Skin Spectrum Summit Announce 2024 Recipients of the Canadian Skin of Colour & Diversity Scholarship

Sep 24, 2024

Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine

Sep 19, 2024

ABRYSVO(TM): Pfizer Canada's Newly Publicly Funded Vaccine a Step Towards National RSV Prevention in Older Adults

Jun 03, 2024

Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada

Jan 03, 2024

HEALTH CANADA APPROVES PFIZER CANADA'S GENE THERAPY IN HEMOPHILIA B